Trials / Unknown
UnknownNCT05249244
A Real World Study of the Treatment of Gastric Adenocarcinoma With Huachansu
A Real World Study of the Treatment of Locally-inoperable Advanced or Advanced Metastatic Gastric Adenocarcinoma With Huachansu
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of huachansu oral preparation in the treatment of inoperable locally advanced or advanced metastatic gastric adenocarcinoma, including gastric esophageal adenocarcinoma.
Detailed description
In this multicenter, controlled, retrospective, real-world study, the original medical records of participants diagnosed with inoperable locally advanced or advanced metastatic gastric adenocarcinoma (including gastric esophageal junction adenocarcinoma) receive treatment in research centers from January 1, 2014 to December 31, 2019 were collected. To evaluate the efficacy and safety of oral huachansu in the systematic treatment of locally advanced or advanced metastatic gastric adenocarcinoma.
Conditions
Timeline
- Start date
- 2021-07-01
- Primary completion
- 2021-12-31
- Completion
- 2022-02-28
- First posted
- 2022-02-21
- Last updated
- 2022-02-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05249244. Inclusion in this directory is not an endorsement.